<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37596282</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>18</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Reactivated endogenous retroviruses promote protein aggregate spreading.</ArticleTitle><Pagination><StartPage>5034</StartPage><MedlinePgn>5034</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5034</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-40632-z</ELocationID><Abstract><AbstractText>Prion-like spreading of protein misfolding is a&#xa0;characteristic of neurodegenerative diseases, but the exact mechanisms of intercellular protein aggregate dissemination remain unresolved. Evidence accumulates that endogenous retroviruses, remnants of viral germline infections that are normally epigenetically silenced, become upregulated in neurodegenerative diseases such as amyotrophic lateral sclerosis and tauopathies. Here we uncover that activation of endogenous retroviruses affects prion-like spreading of proteopathic seeds. We show that upregulation of endogenous retroviruses drastically increases the dissemination of protein aggregates between cells in culture, a process that can be inhibited by targeting the viral envelope protein or viral protein processing. Human endogenous retrovirus envelopes of four different clades also elevate intercellular spreading of proteopathic seeds, including pathological Tau. Our data support a role of endogenous retroviruses in protein misfolding diseases and suggest that antiviral drugs could represent promising candidates for inhibiting protein aggregate spreading.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases Bonn (DZNE), Venusberg Campus 1/ 99, 53127, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Federal Institute for Risk Assessment (BfR), German Centre for the Protection of Laboratory Animals (Bf3R), Max-Dohrn-Stra&#xdf;e 8-10, 10589, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Heum&#xfc;ller</LastName><ForeName>Stefanie-Elisabeth</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases Bonn (DZNE), Venusberg Campus 1/ 99, 53127, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hossinger</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases Bonn (DZNE), Venusberg Campus 1/ 99, 53127, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Stephan A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0003-3414-307X</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buravlova</LastName><ForeName>Oleksandra</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases Bonn (DZNE), Venusberg Campus 1/ 99, 53127, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lichtenthaler</LastName><ForeName>Stefan F</ForeName><Initials>SF</Initials><Identifier Source="ORCID">0000-0003-2211-2575</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, 81675, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denner</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases Bonn (DZNE), Venusberg Campus 1/ 99, 53127, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vorberg</LastName><ForeName>Ina M</ForeName><Initials>IM</Initials><Identifier Source="ORCID">0000-0003-0583-4015</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases Bonn (DZNE), Venusberg Campus 1/ 99, 53127, Bonn, Germany. ina.vorberg@dzne.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Rheinische Friedrich-Wilhelms-Universit&#xe4;t Bonn, Germany, Venusberg-Campus 1, 53127, Bonn, Germany. ina.vorberg@dzne.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011328">Prions</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020077" MajorTopicYN="Y">Endogenous Retroviruses</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011328" MajorTopicYN="Y">Prions</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>S.L., S.A.M., S.F.L., P.D., and I.M.V. hold pending patent applications for &#x201c;HERV inhibitors for use in treating tauopathies&#x201d;: &#x201c;US Patent Application No. 17/640,119 based on PCT International Application No. PCT/EP2020/074809, claiming priority to &#x201c;European Application No. 19195304.1&#x201d;. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>19</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>23</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37596282</ArticleId><ArticleId IdType="pmc">PMC10439213</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-40632-z</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-40632-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>La Joie R, et al. Prospective longitudinal atrophy in Alzheimer&#x2019;s disease correlates with the intensity and topography of baseline tau-PET. Sci. Transl. Med. 2020;12:eaau5732. doi: 10.1126/scitranslmed.aau5732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aau5732</ArticleId><ArticleId IdType="pmc">PMC7035952</ArticleId><ArticleId IdType="pubmed">31894103</ArticleId></ArticleIdList></Reference><Reference><Citation>Valori CF, Neumann M. Contribution of RNA/DNA binding protein dysfunction in oligodendrocytes in the pathogenesis of the amyotrophic lateral sclerosis/frontotemporal lobar degeneration spectrum diseases. Front. Neurosci. 2021;15:724891. doi: 10.3389/fnins.2021.724891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.724891</ArticleId><ArticleId IdType="pmc">PMC8440855</ArticleId><ArticleId IdType="pubmed">34539339</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991;82:239&#x2013;259. doi: 10.1007/BF00308809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00308809</ArticleId><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavaguera F, et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 2009;11:909&#x2013;913. doi: 10.1038/ncb1901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1901</ArticleId><ArticleId IdType="pmc">PMC2726961</ArticleId><ArticleId IdType="pubmed">19503072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman SK, et al. Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron. 2016;92:796&#x2013;812. doi: 10.1016/j.neuron.2016.09.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.055</ArticleId><ArticleId IdType="pmc">PMC5392364</ArticleId><ArticleId IdType="pubmed">27974162</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunello CA, Merezhko M, Uronen RL, Huttunen HJ. Mechanisms of secretion and spreading of pathological tau protein. Cell. Mol. Life Sci. 2020;77:1721&#x2013;1744. doi: 10.1007/s00018-019-03349-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03349-1</ArticleId><ArticleId IdType="pmc">PMC7190606</ArticleId><ArticleId IdType="pubmed">31667556</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, et al. Highly efficient intercellular spreading of protein misfolding mediated by viral ligand&#x2013;receptor interactions. Nat. Commun. 2021;12:5739. doi: 10.1038/s41467-021-25855-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25855-2</ArticleId><ArticleId IdType="pmc">PMC8526834</ArticleId><ArticleId IdType="pubmed">34667166</ArticleId></ArticleIdList></Reference><Reference><Citation>Belshaw R, et al. Rate of recombinational deletion among human endogenous retroviruses. J. Virol. 2007;81:9437&#x2013;9442. doi: 10.1128/JVI.02216-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02216-06</ArticleId><ArticleId IdType="pmc">PMC1951428</ArticleId><ArticleId IdType="pubmed">17581995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kury P, et al. Human endogenous retroviruses in neurological diseases. Trends Mol. Med. 2018;24:379&#x2013;394. doi: 10.1016/j.molmed.2018.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2018.02.007</ArticleId><ArticleId IdType="pmc">PMC7185488</ArticleId><ArticleId IdType="pubmed">29551251</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassiotis G. Endogenous retroviruses and the development of cancer. J. Immunol. 2014;192:1343&#x2013;1349. doi: 10.4049/jimmunol.1302972.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1302972</ArticleId><ArticleId IdType="pmc">PMC3925786</ArticleId><ArticleId IdType="pubmed">24511094</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C, et al. Tau activates transposable elements in Alzheimer&#x2019;s disease. Cell Rep. 2018;23:2874&#x2013;2880. doi: 10.1016/j.celrep.2018.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.05.004</ArticleId><ArticleId IdType="pmc">PMC6181645</ArticleId><ArticleId IdType="pubmed">29874575</ArticleId></ArticleIdList></Reference><Reference><Citation>Protasova MS, et al. Quantitative analysis of L1-retrotransposons in Alzheimer&#x2019;s disease and aging. Biochemistry (Moscow) 2017;82:962&#x2013;971. doi: 10.1134/S0006297917080120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297917080120</ArticleId><ArticleId IdType="pubmed">28941465</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost B, Hemberg M, Lewis J, Feany MB. Tau promotes neurodegeneration through global chromatin relaxation. Nat. Neurosci. 2014;17:357&#x2013;366. doi: 10.1038/nn.3639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3639</ArticleId><ArticleId IdType="pmc">PMC4012297</ArticleId><ArticleId IdType="pubmed">24464041</ArticleId></ArticleIdList></Reference><Reference><Citation>Dembny P, et al. Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors. JCI Insight. 2020;5:e131093. doi: 10.1172/jci.insight.131093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.131093</ArticleId><ArticleId IdType="pmc">PMC7205273</ArticleId><ArticleId IdType="pubmed">32271161</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W, Samimi H, Gamez M, Zare H, Frost B. Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies. Nat. Neurosci. 2018;21:1038&#x2013;1048. doi: 10.1038/s41593-018-0194-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0194-1</ArticleId><ArticleId IdType="pmc">PMC6095477</ArticleId><ArticleId IdType="pubmed">30038280</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan K, et al. Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia. Commun. Med. (Lond.) 2021;1:60. doi: 10.1038/s43856-021-00060-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-021-00060-w</ArticleId><ArticleId IdType="pmc">PMC8788987</ArticleId><ArticleId IdType="pubmed">35083468</ArticleId></ArticleIdList></Reference><Reference><Citation>Douville R, Liu J, Rothstein J, Nath A. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann. Neurol. 2011;69:141&#x2013;151. doi: 10.1002/ana.22149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22149</ArticleId><ArticleId IdType="pmc">PMC3052883</ArticleId><ArticleId IdType="pubmed">21280084</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj N, Montesion M, Roy F, Coffin JM. Differential expression of HERV-K (HML-2) proviruses in cells and virions of the teratocarcinoma cell line Tera-1. Viruses. 2015;7:939&#x2013;968. doi: 10.3390/v7030939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7030939</ArticleId><ArticleId IdType="pmc">PMC4379556</ArticleId><ArticleId IdType="pubmed">25746218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozak CA. Origins of the endogenous and infectious laboratory mouse gammaretroviruses. Viruses. 2014;7:1&#x2013;26. doi: 10.3390/v7010001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7010001</ArticleId><ArticleId IdType="pmc">PMC4306825</ArticleId><ArticleId IdType="pubmed">25549291</ArticleId></ArticleIdList></Reference><Reference><Citation>Jern P, Stoye JP, Coffin JM. Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genet. 2007;3:2014&#x2013;2022. doi: 10.1371/journal.pgen.0030183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.0030183</ArticleId><ArticleId IdType="pmc">PMC2041998</ArticleId><ArticleId IdType="pubmed">17967065</ArticleId></ArticleIdList></Reference><Reference><Citation>Young GR, et al. Resurrection of endogenous retroviruses in antibody-deficient mice. Nature. 2012;491:774&#x2013;778. doi: 10.1038/nature11599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11599</ArticleId><ArticleId IdType="pmc">PMC3511586</ArticleId><ArticleId IdType="pubmed">23103862</ArticleId></ArticleIdList></Reference><Reference><Citation>King OD, Gitler AD, Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 2012;1462:61&#x2013;80. doi: 10.1016/j.brainres.2012.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.01.016</ArticleId><ArticleId IdType="pmc">PMC3372647</ArticleId><ArticleId IdType="pubmed">22445064</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer C, et al. The yeast Sup35NM domain propagates as a prion in mammalian cells. Proc. Natl Acad. Sci. USA. 2009;106:462&#x2013;467. doi: 10.1073/pnas.0811571106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0811571106</ArticleId><ArticleId IdType="pmc">PMC2626725</ArticleId><ArticleId IdType="pubmed">19114662</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann JP, et al. Cell-to-cell propagation of infectious cytosolic protein aggregates. Proc. Natl Acad. Sci. USA. 2013;110:5951&#x2013;5956. doi: 10.1073/pnas.1217321110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217321110</ArticleId><ArticleId IdType="pmc">PMC3625284</ArticleId><ArticleId IdType="pubmed">23509289</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Hossinger A, Hofmann JP, Denner P, Vorberg IM. Horizontal transmission of cytosolic Sup35 prions by extracellular vesicles. MBio. 2016;7:e00915&#x2013;e00916. doi: 10.1128/mBio.00915-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00915-16</ArticleId><ArticleId IdType="pmc">PMC4958257</ArticleId><ArticleId IdType="pubmed">27406566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieber MM, Todaro GJ. Spontaneous and induced production of endogenous type-C RNA virus from a clonal line of spontaneously transformed BALB-3T3. Int. J. Cancer J. Int. Cancer. 1973;11:616&#x2013;627. doi: 10.1002/ijc.2910110313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.2910110313</ArticleId><ArticleId IdType="pubmed">4133949</ArticleId></ArticleIdList></Reference><Reference><Citation>Alais S, et al. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles. Biol. Cell/auspices Eur. Cell Biol. Organ. 2008;100:603&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">18422484</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Xu F, Muller J, Hearing VJ, Gorelik E. Ecotropic C-type retrovirus of B16 melanoma and malignant transformation of normal melanocytes. Int. J. Cancer J. Int. Cancer. 1998;76:430&#x2013;436. doi: 10.1002/(SICI)1097-0215(19980504)76:3&lt;430::AID-IJC23&gt;3.0.CO;2-D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0215(19980504)76:3&lt;430::AID-IJC23&gt;3.0.CO;2-D</ArticleId><ArticleId IdType="pubmed">9579583</ArticleId></ArticleIdList></Reference><Reference><Citation>Radek C, et al. Vectofusin-1 improves transduction of primary human cells with diverse retroviral and lentiviral pseudotypes, enabling robust, automated closed-system manufacturing. Hum. Gene Ther. 2019;30:1477&#x2013;1493. doi: 10.1089/hum.2019.157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2019.157</ArticleId><ArticleId IdType="pmc">PMC6919281</ArticleId><ArticleId IdType="pubmed">31578886</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin JG, Grimley PM, Ramseur JM, Berezesky IK. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J. Virol. 1974;14:152&#x2013;161. doi: 10.1128/jvi.14.1.152-161.1974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.14.1.152-161.1974</ArticleId><ArticleId IdType="pmc">PMC355489</ArticleId><ArticleId IdType="pubmed">4134468</ArticleId></ArticleIdList></Reference><Reference><Citation>Dettenhofer M, Yu XF. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J. Virol. 1999;73:1460&#x2013;1467. doi: 10.1128/JVI.73.2.1460-1467.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.2.1460-1467.1999</ArticleId><ArticleId IdType="pmc">PMC103971</ArticleId><ArticleId IdType="pubmed">9882352</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe HM, Trono D. Dynamic control of endogenous retroviruses during development. Virology. 2011;411:273&#x2013;287. doi: 10.1016/j.virol.2010.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.12.007</ArticleId><ArticleId IdType="pubmed">21251689</ArticleId></ArticleIdList></Reference><Reference><Citation>Strick R, Strissel PL, Baylin SB, Chiappinelli KB. Unraveling the molecular pathways of DNA-methylation inhibitors: human endogenous retroviruses induce the innate immune response in tumors. Oncoimmunology. 2016;5:e1122160. doi: 10.1080/2162402X.2015.1122160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/2162402X.2015.1122160</ArticleId><ArticleId IdType="pmc">PMC4910697</ArticleId><ArticleId IdType="pubmed">27467919</ArticleId></ArticleIdList></Reference><Reference><Citation>Rein A, Mirro J, Haynes JG, Ernst SM, Nagashima K. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 1994;68:1773&#x2013;1781. doi: 10.1128/jvi.68.3.1773-1781.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.68.3.1773-1781.1994</ArticleId><ArticleId IdType="pmc">PMC236638</ArticleId><ArticleId IdType="pubmed">8107239</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshima M, et al. Effects of blocking individual maturation cleavages in murine leukemia virus gag. J. Virol. 2004;78:1411&#x2013;1420. doi: 10.1128/JVI.78.3.1411-1420.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.3.1411-1420.2004</ArticleId><ArticleId IdType="pmc">PMC321369</ArticleId><ArticleId IdType="pubmed">14722296</ArticleId></ArticleIdList></Reference><Reference><Citation>Feher A, et al. Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease. J. Gen. Virol. 2006;87:1321&#x2013;1330. doi: 10.1099/vir.0.81382-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81382-0</ArticleId><ArticleId IdType="pubmed">16603535</ArticleId></ArticleIdList></Reference><Reference><Citation>Bamunusinghe D, Liu Q, Lu X, Oler A, Kozak CA. Endogenous gammaretrovirus acquisition in Mus musculus subspecies carrying functional variants of the XPR1 virus receptor. J. Virol. 2013;87:9845&#x2013;9855. doi: 10.1128/JVI.01264-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01264-13</ArticleId><ArticleId IdType="pmc">PMC3754108</ArticleId><ArticleId IdType="pubmed">23824809</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy JA, Kazan P, Varnier O, Kleiman H. Murine xenotropic type C viruses I. Distribution and further characterization of the virus in NZB mice. J. Virol. 1975;16:844&#x2013;853. doi: 10.1128/jvi.16.4.844-853.1975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.16.4.844-853.1975</ArticleId><ArticleId IdType="pmc">PMC354744</ArticleId><ArticleId IdType="pubmed">170419</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty P, et al. Co-factor-free aggregation of tau into seeding-competent RNA-sequestering amyloid fibrils. Nat. Commun. 2021;12:4231. doi: 10.1038/s41467-021-24362-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24362-8</ArticleId><ArticleId IdType="pmc">PMC8270918</ArticleId><ArticleId IdType="pubmed">34244499</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian RP, Wildschutte JH, Russo C, Coffin JM. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology. 2011;8:90. doi: 10.1186/1742-4690-8-90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-8-90</ArticleId><ArticleId IdType="pmc">PMC3228705</ArticleId><ArticleId IdType="pubmed">22067224</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanke K, et al. Reconstitution of the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional activity by truncation of the cytoplasmic domain. J. Virol. 2009;83:12790&#x2013;12800. doi: 10.1128/JVI.01368-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01368-09</ArticleId><ArticleId IdType="pmc">PMC2786854</ArticleId><ArticleId IdType="pubmed">19812154</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavillette D, et al. The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors. J. Virol. 2002;76:6442&#x2013;6452. doi: 10.1128/JVI.76.13.6442-6452.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.13.6442-6452.2002</ArticleId><ArticleId IdType="pmc">PMC136247</ArticleId><ArticleId IdType="pubmed">12050356</ArticleId></ArticleIdList></Reference><Reference><Citation>Blond JL, et al. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J. Virol. 2000;74:3321&#x2013;3329. doi: 10.1128/JVI.74.7.3321-3329.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.7.3321-3329.2000</ArticleId><ArticleId IdType="pmc">PMC111833</ArticleId><ArticleId IdType="pubmed">10708449</ArticleId></ArticleIdList></Reference><Reference><Citation>Drewlo S, Leyting S, Kokozidou M, Mallet F, Potgens AJ. C-Terminal truncations of syncytin-1 (ERVWE1 envelope) that increase its fusogenicity. Biol. Chem. 2006;387:1113&#x2013;1120. doi: 10.1515/BC.2006.137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/BC.2006.137</ArticleId><ArticleId IdType="pubmed">16895482</ArticleId></ArticleIdList></Reference><Reference><Citation>Antony JM, et al. The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes. J. Immunol. 2007;179:1210&#x2013;1224. doi: 10.4049/jimmunol.179.2.1210.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.2.1210</ArticleId><ArticleId IdType="pubmed">17617614</ArticleId></ArticleIdList></Reference><Reference><Citation>Antony JM, et al. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat. Neurosci. 2004;7:1088&#x2013;1095. doi: 10.1038/nn1319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1319</ArticleId><ArticleId IdType="pubmed">15452578</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci. Transl. Med. 2015;7:307ra153. doi: 10.1126/scitranslmed.aac8201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aac8201</ArticleId><ArticleId IdType="pmc">PMC6344353</ArticleId><ArticleId IdType="pubmed">26424568</ArticleId></ArticleIdList></Reference><Reference><Citation>Bamunusinghe D, et al. Recombinant origins of pathogenic and nonpathogenic mouse gammaretroviruses with polytropic host range. J. Virol. 2017;91:e00855&#x2013;17. doi: 10.1128/JVI.00855-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00855-17</ArticleId><ArticleId IdType="pmc">PMC5640873</ArticleId><ArticleId IdType="pubmed">28794032</ArticleId></ArticleIdList></Reference><Reference><Citation>Pothlichet J, Heidmann T, Mangeney M. A recombinant endogenous retrovirus amplified in a mouse neuroblastoma is involved in tumor growth in vivo. Int. J. Cancer J. Int. du cancer. 2006;119:815&#x2013;822. doi: 10.1002/ijc.21935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.21935</ArticleId><ArticleId IdType="pubmed">16550601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottina E, et al. Restoration of endogenous retrovirus infectivity impacts mouse cancer models. Cancer Immunol. Res. 2018;6:1292&#x2013;1300. doi: 10.1158/2326-6066.CIR-18-0038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2326-6066.CIR-18-0038</ArticleId><ArticleId IdType="pmc">PMC6485373</ArticleId><ArticleId IdType="pubmed">30143537</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory DA, Lyddon TD, Johnson MC. Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions. J. Virol. 2013;87:1518&#x2013;1527. doi: 10.1128/JVI.02604-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02604-12</ArticleId><ArticleId IdType="pmc">PMC3554149</ArticleId><ArticleId IdType="pubmed">23152533</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Souza V, Summers MF. How retroviruses select their genomes. Nat. Rev. Microbiol. 2005;3:643&#x2013;655. doi: 10.1038/nrmicro1210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1210</ArticleId><ArticleId IdType="pubmed">16064056</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain. 2016;139:3187&#x2013;3201. doi: 10.1093/brain/aww237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww237</ArticleId><ArticleId IdType="pmc">PMC5840881</ArticleId><ArticleId IdType="pubmed">27679482</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero D, et al. Pathological proteins are transported by extracellular vesicles of sporadic amyotrophic lateral sclerosis patients. Front. Neurosci. 2018;12:487. doi: 10.3389/fnins.2018.00487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00487</ArticleId><ArticleId IdType="pmc">PMC6060258</ArticleId><ArticleId IdType="pubmed">30072868</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblanc P, et al. Retrovirus infection strongly enhances scrapie infectivity release in cell culture. EMBO J. 2006;25:2674&#x2013;2685. doi: 10.1038/sj.emboj.7601162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7601162</ArticleId><ArticleId IdType="pmc">PMC1500854</ArticleId><ArticleId IdType="pubmed">16724107</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblanc P, et al. Co-infection with the friend retrovirus and mouse scrapie does not alter prion disease pathogenesis in susceptible mice. PLoS ONE. 2012;7:e30872. doi: 10.1371/journal.pone.0030872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030872</ArticleId><ArticleId IdType="pmc">PMC3266293</ArticleId><ArticleId IdType="pubmed">22295118</ArticleId></ArticleIdList></Reference><Reference><Citation>Maksakova IA, et al. Retroviral elements and their hosts: insertional mutagenesis in the mouse germ line. PLoS Genet. 2006;2:e2. doi: 10.1371/journal.pgen.0020002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.0020002</ArticleId><ArticleId IdType="pmc">PMC1331978</ArticleId><ArticleId IdType="pubmed">16440055</ArticleId></ArticleIdList></Reference><Reference><Citation>Lower R, Lower J, Frank H, Harzmann R, Kurth R. Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses. J. Gen. Virol. 1984;65:887&#x2013;898. doi: 10.1099/0022-1317-65-5-887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-65-5-887</ArticleId><ArticleId IdType="pubmed">6202829</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono M, Kawakami M, Ushikubo H. Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J. Virol. 1987;61:2059&#x2013;2062. doi: 10.1128/jvi.61.6.2059-2062.1987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.61.6.2059-2062.1987</ArticleId><ArticleId IdType="pmc">PMC254220</ArticleId><ArticleId IdType="pubmed">2883329</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowers EC, Motta A, Knox K, McKay BS, Ramos KS. LINE-1 cargo and reverse transcriptase activity profiles in extracellular vesicles from lung cancer cells and human plasma. Int. J. Mol. Sci. 2022;23:3461. doi: 10.3390/ijms23073461.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23073461</ArticleId><ArticleId IdType="pmc">PMC8998977</ArticleId><ArticleId IdType="pubmed">35408821</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas A, et al. Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia. FASEB J. 2014;28:3703&#x2013;3719. doi: 10.1096/fj.13-239053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.13-239053</ArticleId><ArticleId IdType="pubmed">24812088</ArticleId></ArticleIdList></Reference><Reference><Citation>Arru G, et al. Humoral immunity response to human endogenous retroviruses K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases. Eur. J. Neurol. 2018;25:1076&#x2013;e1084. doi: 10.1111/ene.13648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13648</ArticleId><ArticleId IdType="pubmed">29603839</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner JP, et al. Human endogenous retrovirus K envelope in spinal fluid of amyotrophic lateral sclerosis is toxic. Ann. Neurol. 2022;92:545&#x2013;561. doi: 10.1002/ana.26452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26452</ArticleId><ArticleId IdType="pmc">PMC9489628</ArticleId><ArticleId IdType="pubmed">35801347</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Chen Y, Zhang N, Fan D. Human endogenous retrovirus K (HERV-K) env in neuronal extracellular vesicles: a new biomarker of motor neuron disease. Amyotroph. Lateral Scler. Frontotemporal Degener. 2022;23:100&#x2013;107. doi: 10.1080/21678421.2021.1936061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1936061</ArticleId><ArticleId IdType="pubmed">34151656</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong BH, Lee YJ, Carp RI, Kim YS. The prevalence of human endogenous retroviruses in cerebrospinal fluids from patients with sporadic Creutzfeldt&#x2013;Jakob disease. J. Clin. Virol. 2010;47:136&#x2013;142. doi: 10.1016/j.jcv.2009.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2009.11.016</ArticleId><ArticleId IdType="pubmed">20005155</ArticleId></ArticleIdList></Reference><Reference><Citation>Charvet B, et al. Human endogenous retrovirus type W envelope from multiple sclerosis demyelinating lesions shows unique solubility and antigenic characteristics. Virol. Sin. 2021;36:1006&#x2013;1026. doi: 10.1007/s12250-021-00372-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-021-00372-0</ArticleId><ArticleId IdType="pmc">PMC8558138</ArticleId><ArticleId IdType="pubmed">33770381</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwood AD, et al. Bovine spongiform encephalopathy infection alters endogenous retrovirus expression in distinct brain regions of cynomolgus macaques (Macaca fascicularis) Mol. Neurodegener. 2011;6:44. doi: 10.1186/1750-1326-6-44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-44</ArticleId><ArticleId IdType="pmc">PMC3152937</ArticleId><ArticleId IdType="pubmed">21699683</ArticleId></ArticleIdList></Reference><Reference><Citation>Akowitz A, Sklaviadis T, Manuelidis L. Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt&#x2013;Jakob disease. Nucleic Acids Res. 1994;22:1101&#x2013;1107. doi: 10.1093/nar/22.6.1101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/22.6.1101</ArticleId><ArticleId IdType="pmc">PMC307936</ArticleId><ArticleId IdType="pubmed">8152913</ArticleId></ArticleIdList></Reference><Reference><Citation>Romer C. Viruses and endogenous retroviruses as roots for neuroinflammation and neurodegenerative diseases. Front. Neurosci. 2021;15:648629. doi: 10.3389/fnins.2021.648629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.648629</ArticleId><ArticleId IdType="pmc">PMC7994506</ArticleId><ArticleId IdType="pubmed">33776642</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer P, et al. The human endogenous retrovirus K(HML-2) has a broad envelope-mediated cellular tropism and is prone to inhibition at a post-entry, pre-integration step. Virology. 2016;487:121&#x2013;128. doi: 10.1016/j.virol.2015.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.10.014</ArticleId><ArticleId IdType="pubmed">26517399</ArticleId></ArticleIdList></Reference><Reference><Citation>Uygur B, Melikov K, Arakelyan A, Margolis LB, Chernomordik LV. Syncytin 1 dependent horizontal transfer of marker genes from retrovirally transduced cells. Sci. Rep. 2019;9:17637. doi: 10.1038/s41598-019-54178-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-54178-y</ArticleId><ArticleId IdType="pmc">PMC6881383</ArticleId><ArticleId IdType="pubmed">31776415</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitao K, Tanikaga T, Miyazawa T. Identification of a post-transcriptional regulatory element in the human endogenous retroviral syncytin-1. J. Gen. Virol. 2019;100:662&#x2013;668. doi: 10.1099/jgv.0.001238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001238</ArticleId><ArticleId IdType="pubmed">30794119</ArticleId></ArticleIdList></Reference><Reference><Citation>Sena-Esteves M, Tebbets JC, Steffens S, Crombleholme T, Flake AW. Optimized large-scale production of high titer lentivirus vector pseudotypes. J. Virol. Methods. 2004;122:131&#x2013;139. doi: 10.1016/j.jviromet.2004.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2004.08.017</ArticleId><ArticleId IdType="pubmed">15542136</ArticleId></ArticleIdList></Reference><Reference><Citation>Woerman AL, et al. Tau prions from Alzheimer&#x2019;s disease and chronic traumatic encephalopathy patients propagate in cultured cells. Proc. Natl Acad. Sci. USA. 2016;113:E8187&#x2013;E8196. doi: 10.1073/pnas.1616344113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1616344113</ArticleId><ArticleId IdType="pmc">PMC5167200</ArticleId><ArticleId IdType="pubmed">27911827</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat. Methods. 2009;6:359&#x2013;362. doi: 10.1038/nmeth.1322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1322</ArticleId><ArticleId IdType="pubmed">19377485</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappsilber J, Ishihama Y, Mann M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 2003;75:663&#x2013;670. doi: 10.1021/ac026117i.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac026117i</ArticleId><ArticleId IdType="pubmed">12585499</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J, et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteom. 2014;13:2513&#x2013;2526. doi: 10.1074/mcp.M113.031591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M113.031591</ArticleId><ArticleId IdType="pmc">PMC4159666</ArticleId><ArticleId IdType="pubmed">24942700</ArticleId></ArticleIdList></Reference><Reference><Citation>Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA. 2001;98:5116&#x2013;5121. doi: 10.1073/pnas.091062498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.091062498</ArticleId><ArticleId IdType="pmc">PMC33173</ArticleId><ArticleId IdType="pubmed">11309499</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans LH, Morrison RP, Malik FG, Portis J, Britt WJ. A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J. Virol. 1990;64:6176&#x2013;6183. doi: 10.1128/jvi.64.12.6176-6183.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.64.12.6176-6183.1990</ArticleId><ArticleId IdType="pmc">PMC248792</ArticleId><ArticleId IdType="pubmed">1700832</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshinobu K, et al. Selective up-regulation of intact, but not defective env RNAs of endogenous modified polytropic retrovirus by the Sgp3 locus of lupus-prone mice. J. Immunol. 2009;182:8094&#x2013;8103. doi: 10.4049/jimmunol.0900263.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0900263</ArticleId><ArticleId IdType="pmc">PMC2792900</ArticleId><ArticleId IdType="pubmed">19494335</ArticleId></ArticleIdList></Reference><Reference><Citation>Treger RS, et al. Human APOBEC3G prevents emergence of infectious endogenous retrovirus in mice. J. Virol. 2019;93:e00728&#x2013;19. doi: 10.1128/JVI.00728-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00728-19</ArticleId><ArticleId IdType="pmc">PMC6798113</ArticleId><ArticleId IdType="pubmed">31341050</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankowski R, et al. Endogenous retroviruses are associated with hippocampus-based memory impairment. Proc. Natl Acad. Sci. USA. 2019;116:25982&#x2013;25990. doi: 10.1073/pnas.1822164116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1822164116</ArticleId><ArticleId IdType="pmc">PMC6925997</ArticleId><ArticleId IdType="pubmed">31792184</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Riverol Y, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50:D543&#x2013;D552. doi: 10.1093/nar/gkab1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1038</ArticleId><ArticleId IdType="pmc">PMC8728295</ArticleId><ArticleId IdType="pubmed">34723319</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozak CA. The mouse &#x201c;xenotropic&#x201d; gammaretroviruses and their XPR1 receptor. Retrovirology. 2010;7:101. doi: 10.1186/1742-4690-7-101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-7-101</ArticleId><ArticleId IdType="pmc">PMC3009702</ArticleId><ArticleId IdType="pubmed">21118532</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>